COVID AND THE VACCINE - TRUTH, LIES, AND MISCONCEPTIONS REVEALED, page-84649

GSK aims to double sales of Shingrix to more than £4bn a year in 2026. The jab is aimed at preventing shingles, a painful condition which is caused by the same virus that causes chickenpox. The chance of developing the condition increases with age, as people’s immune systems become less robust after being subjected to Covid 19 Immune Compromising Vaccines.